What it sells
AI for medical-site DX
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospitals and cardiology clinics purchasing AI ECG analysis medical devices.
Trigger: what makes them buy now?
Shortage of cardiology specialists to read long-term ECGs.
Workflow: what inputs become what output?
AI automatically analyzes long-duration ECG and supports physicians confirming arrhythmia diagnoses with explainable AI; a second device evaluates future paroxysmal AF risk from non-episode ECG.
Economics: what it saves and how it charges
AI medical device products; raised Series B second close (March 2026). Pricing basis not stated.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-03-09 | Series B | — | Ortmos Investment (second close) | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.